Phibro Animal Health Corporation $PAHC Stock Position Raised by Russell Investments Group Ltd.

Key Points

• Russell Investments Group Ltd. significantly increased its holdings in Phibro Animal Health Corporation by 711.1%, owning 122,600 shares worth approximately $2.62 million.
• Several institutional investors, including Nuveen LLC and Invesco Ltd., also acquired substantial positions in Phibro Animal Health, with 99.34% of the stock currently held by institutional investors.
• Wall Street analysts have shown optimism for the company, with upgrades from JPMorgan Chase & Co. and others, raising the target price to as high as $35.00.

Russell Investments Group Ltd. lifted its holdings in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 711.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 122,600 shares of the company's stock after acquiring an additional 107,485 shares during the quarter. Russell Investments Group Ltd. owned about 0.30% of Phibro Animal Health worth $2,619,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in shares of Phibro Animal Health by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock valued at $32,500,000 after acquiring an additional 6,784 shares in the last quarter. Nuveen Asset Management LLC lifted its holdings in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after buying an additional 103,618 shares in the last quarter. Nuveen LLC acquired a new position in Phibro Animal Health in the 1st quarter worth $10,312,000. CastleKnight Management LP lifted its holdings in Phibro Animal Health by 6.2% in the 4th quarter. CastleKnight Management LP now owns 389,433 shares of the company's stock worth $8,178,000 after buying an additional 22,796 shares in the last quarter. Finally, Invesco Ltd. lifted its holdings in Phibro Animal Health by 92.3% in the 1st quarter. Invesco Ltd. now owns 387,739 shares of the company's stock worth $8,282,000 after buying an additional 186,087 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Stock Up 19.4%

Shares of PAHC traded up $6.26 during midday trading on Thursday, hitting $38.46. The company had a trading volume of 1,069,800 shares, compared to its average volume of 265,800. The company's 50 day moving average price is $28.78 and its 200 day moving average price is $24.29. The stock has a market cap of $1.56 billion, a price-to-earnings ratio of 49.31, a PEG ratio of 0.55 and a beta of 0.80. Phibro Animal Health Corporation has a 52 week low of $16.16 and a 52 week high of $38.83. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.05. The company had revenue of $378.70 million during the quarter, compared to the consensus estimate of $362.24 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. On average, equities research analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 3rd. Phibro Animal Health's dividend payout ratio is currently 61.54%.

Analyst Ratings Changes

A number of brokerages have commented on PAHC. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective on the stock in a report on Monday, June 16th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $25.00 to $35.00 in a report on Monday, July 7th. Finally, Morgan Stanley set a $26.00 price objective on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a report on Wednesday, June 25th. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Reduce" and a consensus price target of $24.40.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.